Vericel Corp·4

Jun 30, 4:05 PM ET

Flynn Sean C. 4

4 · Vericel Corp · Filed Jun 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Vericel (VCEL) CLO Sean Flynn Exercises Options, Sells 15,000 Shares

What Happened
Sean C. Flynn, Chief Legal Officer of Vericel Corp (VCEL), exercised options and sold shares on June 26, 2026. The Form 4 reports Flynn exercised 15,000 shares at a $16.25 strike (cost $243,750) and concurrently sold 15,000 shares in the open market for $45.64 each (gross proceeds $684,600). The filing also shows an additional 15,000-share derivative acquisition recorded at $0.00. The sale was executed under an automatic Rule 10b5-1 trading plan.

Key Details

  • Transaction date: 2026-06-26 (reported on Form 4 filed 2026-06-30; filing is within required business-day window).
  • Exercises/acquisitions: 15,000 shares @ $16.25 (acquired; $243,750); 15,000 shares @ $0.00 (acquired; $0 reported).
  • Sale: 15,000 shares disposed @ $45.64 — gross proceeds $684,600.
  • Footnotes: F2 — sale effected automatically under a Rule 10b5-1 plan adopted 12/02/2025; F1 — some shares in the filing relate to ESPP transactions exempt under Rule 16b-3; F3 — options referenced (150,000 total) became exercisable beginning 11/04/2020 with standard vesting.
  • Shares owned after the transactions: not specified in the information provided in your summary.

Context

  • Transaction code M denotes exercise/conversion of a derivative security (options); the filing shows the exercised shares were sold the same day, consistent with a cashless or sell-to-cover pattern and the use of a pre-existing 10b5-1 sales plan.
  • Sales executed under a 10b5-1 plan are prearranged and typically viewed as routine rather than a spontaneous market-timing signal.
  • This is a factual filing of insider activity — it reports transactions but does not disclose Flynn’s motivations.

Insider Transaction Report

Form 4
Period: 2026-06-26
Flynn Sean C.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-26$16.25/sh+15,000$243,75016,647 total
  • Sale

    Common Stock

    [F2][F1]
    2026-06-26$45.64/sh15,000$684,6001,647 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-06-26+15,00055,000 total
    Exercise: $16.25Exp: 2029-11-04Common Stock (15,000 underlying)
Footnotes (3)
  • [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • [F3]These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Signature
/s/ Sean Flynn|2026-06-30

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4